Skip to content
  • Saturday, 12 September 2026
  • 7:10 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Novo Nordisk’s triple agonist UBT251 delivered up to 19.7% average weight loss in Phase 2 trial
Laboratory Automation & Robotics

Novo Nordisk’s triple agonist UBT251 delivered up to 19.7% average weight loss in Phase 2 trial

Lana Keisha Apr 20, 2026 0

Novo Nordisk, a global leader in diabetes and obesity care, has announced promising results from a Phase 2 trial of…

Read More
Unveiling the Secrets of Peroxisome Growth Control: A Crucial Mechanism for Early Plant Life and BeyondAfrica’s Great Rift Valley: A Continent on the Brink of DivisionThe Paradoxical Protein: Sea Anemones Reveal a Novel Antiviral Defense Strategy, Challenging Evolutionary AssumptionsThe Naked Mole Rat’s Secret to Longevity: A Gene Transfer Breakthrough Offers Hope for Healthier Aging in Mammals
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
Breakthrough High-Resolution Imaging Technique Unlocks Hidden Complexities of Mouse Bone Marrow for Advanced Disease ResearchA novel immune organ inside the skull directs brain defense and may offer a new way to fight brain cancer and neurodegenerative diseaseThe oral exposure challenge in PROTACs: What drug developers need to solve earlyAttention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological Landscape
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Breakthrough High-Resolution Imaging Technique Unlocks Hidden Complexities of Mouse Bone Marrow for Advanced Disease Research
Dwi Wanna Sep 12, 2026
Biotech & Genetic Research
A novel immune organ inside the skull directs brain defense and may offer a new way to fight brain cancer and neurodegenerative disease
Jia Lissa Sep 12, 2026
Laboratory Automation & Robotics
The oral exposure challenge in PROTACs: What drug developers need to solve early
Lana Keisha Sep 12, 2026
Neuroscience & Brain Research
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological Landscape
Rifan Muazin Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ